REF Reformation
Reformation earnings company data as of 4:51 AM ET 10/23
- 1 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 10 Dec | EPS | 0.02 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 10 Sep | EPS | 0.20 | 0.23 | Beat +15.0% |
| Rev | $154.4M | $155.2M | Beat +0.5% |
Insider trades
Open-market buys and sales by REF's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $3.1M bought by 3 insiders
- $61.4M sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Brigitte Kleine DirectorBuy$3,000 200 shares at $15.00 +2.1% to stakeTraded Jul 31 Filed Oct 9
-
Zipporah Allen DirectorBuy$53K 3,500 shares at $15.00 +38% to stakeTraded Jul 31 Filed Oct 9
-
John Joseph Coyle DirectorBuy$3M 200,000 shares at $15.00 +302% to stakeTraded Jul 31 Filed Oct 9
-
Yael Aflalo DirectorSale$841K 60,298 shares at $13.95 0.5% of stakeTraded Sep 1 Filed Sep 3
-
SCSp Refo 10% owner, +3 joint filersSale$2.1M 149,596 shares at $13.95 0.5% of stakeTraded Sep 1 Filed Sep 3
-
SCSp Refo 10% owner, +3 joint filersSale$41.7M 2,987,199 shares at $13.95 9.3% of stakeTraded Jul 31 Filed Jul 31
-
Yael Aflalo DirectorSale$16.8M 1,204,029 shares at $13.95 9.3% of stakeTraded Jul 29 Filed Jul 31
Also filed in the last 12 months, not counted as buying or selling: 13 stock grants and 1 sale back to the company.
SEC filings
Recent issuer filings from EDGAR, 7 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.